STOCK TITAN

QCLS Form 4: Director reports 22,839-share equity award at $0

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Q/C Technologies, Inc. (QCLS) reported an equity award to a director. A board member received 22,839 shares of common stock on November 14, 2025, reported as acquired at a price of $0, bringing this person’s directly held stake to 25,024 shares after the transaction. The shares represent restricted stock units that were originally granted on October 3, 2025 under the company’s 2021 Equity Incentive Plan, subject to stockholder approval of a plan amendment. Stockholders approved that amendment on November 14, 2025, and the RSUs vested immediately upon issuance.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
White Billy Joe

(Last) (First) (Middle)
1185 AVENUE OF THE AMERICAS,
SUITE 249

(Street)
NEW YORK NY 10036

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Q/C TECHNOLOGIES, INC. [ QCLS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
11/14/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common stock 11/14/2025 A 22,839 A $0(1) 25,024 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents a grant of Restricted Stock Units ("RSUs"). The RSUs were granted to the Reporting Person on October 3, 2025, subject to stockholder approval of an amendment to the Issuer's Q/C Technologies, Inc. 2021 Equity Incentive Plan (the "Plan Amendment"), under which the RSUs were granted. The Issuer's stockholders approved the Plan Amendment on November 14, 2025. The RSUs vested immediately upon issuance.
/s/ Billy Joe White 11/17/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Q/C Technologies (QCLS) report in this Form 4?

The filing shows that a director of Q/C Technologies, Inc. (QCLS) acquired 22,839 shares of common stock on November 14, 2025, reported at a price of $0 per share.

How many QCLS shares does the reporting person own after this transaction?

After the reported equity grant, the director beneficially owns 25,024 shares of Q/C Technologies, Inc. common stock in direct ownership.

What is the nature of the QCLS equity award reported on this Form 4?

The transaction represents a grant of Restricted Stock Units (RSUs) that converted into 22,839 common shares of Q/C Technologies, Inc. upon vesting.

When were the QCLS RSUs granted and when did they vest?

The RSUs were granted on October 3, 2025, subject to stockholder approval of a plan amendment, and vested immediately upon issuance after approval on November 14, 2025.

What plan governs the RSU grant reported by Q/C Technologies (QCLS)?

The RSUs were granted under the Q/C Technologies, Inc. 2021 Equity Incentive Plan, as amended by a Plan Amendment that stockholders approved on November 14, 2025.

What is the reporting person’s role at Q/C Technologies, Inc. (QCLS)?

The individual making the Form 4 filing is identified as a Director of Q/C Technologies, Inc.

Q/C Technologies Inc

NASDAQ:QCLS

QCLS Rankings

QCLS Latest News

QCLS Latest SEC Filings

QCLS Stock Data

28.19M
3.71M
In Vitro & in Vivo Diagnostic Substances
NEW YORK